Charles Schwab’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,750
| Closed | -$62.3K | – | 3689 |
|
|
2024
Q1 | $62.3K | Hold |
3,750
| – | – | ﹤0.01% | 3346 |
|
|
2023
Q4 | $60K | Hold |
3,750
| – | – | ﹤0.01% | 3386 |
|
|
2023
Q3 | $286K | Buy |
3,750
+795
| +27% | +$60.5K | ﹤0.01% | 3226 |
|
|
2023
Q2 | $194K | Buy |
+2,955
| New | +$194K | ﹤0.01% | 3310 |
|
|
2022
Q2 | – | Sell |
-1,883
| Closed | -$56K | – | 3662 |
|
|
2022
Q1 | $56K | Hold |
1,883
| – | – | ﹤0.01% | 3512 |
|
|
2021
Q4 | $161K | Buy |
1,883
+546
| +41% | +$46.7K | ﹤0.01% | 3388 |
|
|
2021
Q3 | $100K | Hold |
1,337
| – | – | ﹤0.01% | 3381 |
|
|
2021
Q2 | $125K | Buy |
+1,337
| New | +$125K | ﹤0.01% | 3284 |
|